The medication is administered once weekly via subcutaneous injection, with doses typically initiated at 2.5 mg once weekly for 4 weeks, then escalated (e.g., to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg) based on response and tolerability as per the SmPC
For me, this is intriguing and promising science
Providers typically recommend that patients choose a time they can reliably maintain, as missed doses or irregular administration can compromise glycemic control and weight management outcomes
Nutritional Deficiencies - When appetite is suppressed, people may not meet basic nutritional needs, compounding the risks already present in eating disorders
In Phase 1 and 2a clinical trials, once-daily subcutaneous injections of RG7697 (0.252.5 mg) for 14 days in 56 patients with T2DM and 1.8 mg of RG7697 for 12 weeks in patients with T2DM who were poorly responsive to metformin reduced body weight and improved glycemic control
A licensed provider still has to evaluate you, document medical necessity, and issue a valid prescription